Efficacy of rituximab in thymoma associated minimal change disease: case report

BACKGROUND: Thymomas have been associated with a broad spectrum of autoimmune diseases. Minimal change disease (MCD) is the most frequent pathological lesion reported. Pathophysiological mechanisms involved in secondary MCD, and linking MCD to thymoma are not yet fully explained, although the hypoth...

Descripción completa

Detalles Bibliográficos
Autores principales: El Ouafi, Zhour, Mugnier, Clovis, Jeannet, Robin, Danthu, Clément, Duval, Marion, Belle Mbou, Valère, Touré, Fatouma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425126/
https://www.ncbi.nlm.nih.gov/pubmed/34493204
http://dx.doi.org/10.1186/s12882-021-02479-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425126/
https://www.ncbi.nlm.nih.gov/pubmed/34493204
http://dx.doi.org/10.1186/s12882-021-02479-8

Ejemplares similares